Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Dar Global

    MCap

    USD1,486m

    Last close

    USD8.25

    ▲ −0.25 (−2.94%)

    Theon International

    MCap

    EUR875m

    Last close

    EUR12.50

    ▲ 1.44 (13.02%)

    Metals One

    MCap

    GBP2m

    Last close

    GBP0.00

    ▲ 0.04 (8.89%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Diurnal Group: Edison Open House Healthcare 2022

Diurnal Group: Edison Open House Healthcare 2022

Diurnal Group — 2 videos in collection

More on this equity

Diurnal Group is a specialty pharma company developing new formulations of hormone-based products for the treatment of endocrine disorders.

• Tell us more about the company.
• Is it fair to say there is a high unmet need in this area, as many of the existing treatments are older?
• What is the market opportunity for your drug, Efmody, which was recently launched in the EU and UK?
• What is the importance of the natural rhythms of the body with regard to the dosing schedule for hormonal treatments?
• How big is the market opportunity?
• What are the plans for the development of Efmody in the US?
• Please tell us about your other products, Alkindi and DITEST?
• Which milestones should investors look out for in the coming year?

< Previous
Next >

You may also be interested in these:

Healthcare

Diurnal Group - Edison Open House Interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free